A translational bridge to cancer immunotherapy: Exploiting costimulation and target antigens for active and passive T cell immunotherapy

Author： Vonderheide Robert   June Carl  

Publisher： Humana Press, Inc

ISSN： 0257-277X

Source： Immunologic Research, Vol.27, Iss.2-3, 2003-06, pp. : 341-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer

By Hombach Andreas A   Abken Hinrich  

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 677-681

Future Medicine

Access to resources Recommend Favorite

Tumors as elusive targets of T-cell-based active immunotherapy

By Marincola F.M.   Wang E.   Herlyn M.   Seliger B.   Ferrone S.  

Trends in Immunology, Vol. 24, Iss. 6, 2003-06 ,pp. : 334-341

Elsevier

Access to resources Recommend Favorite

Striving for synergy: how to improve cancer immunotherapy through multiple agonist costimulation

By Adler Adam J   Vella Anthony T  

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1271-1273

Future Medicine

Access to resources Recommend Favorite

Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 3, 2012-07 ,pp. : 224-235

Bentham Science Publishers

Access to resources Recommend Favorite

CD4 T-cell immunotherapy for chronic viral infections and cancer

By Kamphorst Alice O   Ahmed Rafi  

Immunotherapy, Vol. 5, Iss. 9, 2013-09 ,pp. : 975-987

Future Medicine

Access to resources Recommend Favorite